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ABSTRACT
Comparative analysis of mutants using transfection
is complicated by clones exhibiting variable levels
of gene expression due to copy number differences
and genomic position effects. Recombinase-
mediated cassette exchange (RMCE) can overcome
these problems by introducing the target gene
into pre-determined chromosomal loci, but recomb-
ination between the available recombinase targeting
sitescanreducetheefficiencyoftargetedintegration.
We developed a new LoxP site (designated L3),
which when used with the original LoxP site (desig-
nated L2), allows highly efficient and directional
replacement of chromosomal DNA with incoming
DNA. A total of six independent LoxP integration
sites introduced either by homologous recombina-
tion or retroviral delivery were analyzed; 70–80%
of the clones analyzed in hamster and human cells
were correct recombinants. We combined the RMCE
strategy with a new, tightly regulated tetracycline
induction system to produce a robust, highly
reliable system for inducible transgene expression.
We observed stable inducible expression for over
1 month, with uniform expression in the cell popula-
tion and between clones derived from the same
integration site. This system described should find
significant applications for studies requiring high
level and regulated transgene expression and for
determining the effects of various stresses or onco-
genic conditions in vivo and in vitro.
INTRODUCTION
Many studies require the ability to compare the functional
consequences of introducing mutations into genes of interest.
Rigorous comparative analyses require similar gene expres-
sion levels in each stable cell clone. Comparison between
mutant genes is difﬁcult using the common strategy of deriv-
ing stable cell lines as gene expression level is unpredictable
due to variable copies of integrated DNA combined with posi-
tion effects on gene expression. All of these confounding
variables can be eliminated if each transgenic clone is derived
by independently introducing the gene of interest into a pre-
determined genomic locus (1).
Gene targeting by homologous recombination is widely
applied in mouse embryonic stem cells (ES cells) and occa-
sionally in other cell types to produce accurately modiﬁed
loci (2). However, it is a sophisticated and time consuming
procedure that can be compromised by the low recombination
efﬁciency of some loci. Alternatively, the RMCE strategy
uses bacterial and yeast DNA recombinases to target any
DNA sequence into a pre-determined genomic locus that
was previously modiﬁed to contain the appropriate recom-
binaserecognitionsequences(3).Forexample,thewidelyused
bacteriophage P1 Cre/LoxP recombination system utilizes
LoxP sites consisting of two 13 bp inverted repeats and a
central 8 bp spacer sequence. The central 8 bp sequence within
each LoxP site determines if a pair of LoxP sites is compatible
for recombination by Cre (4). LoxP sites containing the same
8 bp core sequences recombine, but LoxP sites differing by
one or more base pairs exhibit reduced or no recombination
(4–6). The success of RMCE relies on the use of two hetero-
speciﬁc LoxPsites (LoxP sites of different sequences) that will
not recombine with each other. Thus, ﬂanking a donor gene of
interest with heterospeciﬁc sites enables it to precisely replace
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of Cre-recombinase. However, the previously published LoxP
sites (L2) and LoxP511 (L1) (4) are not entirely heterospeciﬁc
when tested in mammalian cells, and are consequently not
ideal for RMCE (1,6). For example, deletion of the intervening
sequence occurs when L2 and L1 are placed as direct repeats
on the same DNA, while inversion occurs if they are placed as
inverted repeats (1). Due to the wide usage of RMCE, the
development of new LoxP sites with greater speciﬁcity for
directional exchange is clearly needed.
RMCE can also facilitate structure-function analyses by
ensuring reproducible expression of different mutant alleles
from the same locus. However, the biological signiﬁcance of
such studies can be compromised if the expression level does
not reﬂect that present physiologically. For that, a reliable
inducible system with low basal expression and reproducible
ligand-dependent induction is required. Tight regulation of
gene expression is particularly important if, e.g., the gene
of interest is toxic, or induces cell cycle arrest or apoptosis.
The tetracycline (tet) regulatable system has proven especially
valuable as it uses an inexpensive inducer (doxycycline or
dox), has high dynamic range, low background in un-
induced state and can be used in vivo and in vitro (7).
Regulation in this system involves highly speciﬁc interaction
between the Tet repressor (TetR) and Tet operator (tetO) DNA
sequence (Tet response element or TRE). In the original
Tet-Off system, the DNA binding domain of TetR was fused
with the potent herpes simplex virus VP16 transactivation
domain to form the tetracycline responsive transactivator
(tTA) (8). tTA in the absence of doxycycline (dox) binds
tetO to initiate transcription. The Tet-On system was later
developed due to its wider application in vivo (e.g. for gene
therapy and in transgenic animals) (7,9). Random mutagenesis
of TetR generated a new transactivator (rtTA), which binds
and transactivates gene expression in the presence of dox.
Improved versions of rtTA have been developed to give tighter
gene expression, increased sensitivity towards the inducer,
enhanced stability and expression in mammalian cells,
and more uniform transgene expression in the induced
cells (10,11).
We incorporated the Cre/LoxP and Tet-On systems into
one integrated system to enable tightly regulated induction
of gene expression at reproducible levels between experiments
and in different clones of mammalian cells. A new LoxP site
(L3) was developed to minimize unwanted intrachromosomal
recombinationbetweenheterospeciﬁc LoxPsites. When tested
in two different cell lines and at six independent integration
sites, incoming DNA was correctly targeted at high efﬁcien-
cies. Expression of the reporter gene, luciferase-green ﬂuor-
escence protein fusion (LucGFP) was uniformly induced
across most of the RMCE clones derived from the same integ-
ration site. Such a highly efﬁcient gene targeting approach in
combination with predictable and reproducible gene expres-
sion should ﬁnd wide application in vitro and in vivo.
MATERIALS AND METHODS
Construction of L3
L3 was made from two oligonucleotides that contained 16
complementary (bold) 3-prime residues (50-GGA CTC GAG
ATA ACT TCG TAT AAA GTC TCC TAT A and 50-CCT
ATC GAT ATA ACT TCG TAT AGG AGA CTT TAT A).
The oligos were made duplex by 10 cycles of PCR at an
annealing temperature of 42 C. The result was cloned into
pCR2.1 using TOPO cloning (Invitrogen) and conﬁrmed
by sequencing. The speciﬁcity of L3 derives from an internal
non-repetitive 8 bp sequence (underlined) that deviates from
wild-type at three positions (ATGTATGC).
Plasmids construction
Naming of the wild-type and LoxP511 sites are according to
previously published data (12). pL1L2 and L1HyTK2L were
gifts of S. Fiering (1). pL32L was made by substituting L1,
bounded by XhoI and NcoI in plasmid L1HyTK2L with L3
from pCR2.1-L3, bounded by XhoI (oligonucleotide restric-
tion site in italics above) and BspLU11 I within pCR2.1.
pL3L3 was made from pL32L. L3 was removed with XhoI
and PvuII and re-inserted in the position of 2L using SalI and
SbfI blunted with T4 DNA polymerase.
L3HyTK2L was constructed by replacing L1 in L1HyTK2L
with L3 from pL32L by AhdI and ClaI digestion. The
L3HyTK2L cassette was cloned into a retrovirus backbone
by inserting L3HyTK2L restricted with NotI and XbaI into
pCFB-EGSH (Stratagene) digested with the same enzymes,
generating RV-L3HyTK2L.
To facilitate insertion of genes into the inducible L3-2L
exchange vector, we constructed L3-TRE-MCSpolyA-2L by
cloning the fragment containing seven tetO sites, multiple
cloning sites and a polyadenylation signal derived from
XhoI and SapI/Klenow treated pTRE2 (BD Bioscience) into
L3HyTK2L previously digested with XhoI and PshAI. The
exchange plasmid, L3-TRE-LucGFP-2L (pLi028), was
derived by cloning a BglII-NotI fragment containing LucGFP
from pLuciferase-EGFP (gift from D. Buscher) into BamHI-
NotI sites of L3-TRE-MCSpolyA-2L.
A bicistronic transregulator-expressing cassette was
obtained by amplifying the TetR(B/E)-KRAB (tTR or Tet-
transrepressor) gene by standard PCR using the primers
50-(B/E)-BamHI and 30-(B/E)-BglII, followed by restriction
with BamHI and BglII and ligation with BamHI-restricted
and dephosphorylated pWHE120(sM2), yielding pWHE124.
The polio-virus IRES element was ampliﬁed with 50-P-IRES-
SmaI and 30-P-IRES-SmaI from pCMV-KRAB-rtTA (13),
restricted with SmaI and inserted into likewise-digested and
dephosphorylatedpWHE124, yielding pWHE125-P.Theplas-
mid pWHE134 containing the tricistronic transregulator-
cassette with rtTA2
S-M2, tTR and a neomycin selection
marker separated by two IRES elements was constructed by
restricting pWHE125-P with EcoRI and HpaI and ligating the
fragment encoding the regulatory cassette with pIRESneo (BD
Bioscience) containing the selection marker. pIRESneo had
previouslybeenrestrictedwith BamHI,the50 overhangsﬁlled-
in with T4 DNA polymerase, and then restricted with EcoRI.
All primer and plasmid sequences are available upon request.
Recombination assay by transient transfection
The 293 HEK cells were cotransfected by electroporation with
2 mg of LoxP test plasmid and either 18 mg of GFP expressing
plasmid or 18 mg of Cre-expressing plasmid, pOG231 (14).
Extra-chromosomal DNA was harvested by Hirt extraction
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hybridization after digestion with SspI or NdeI. The probe
used was a 426 bp NcoI-SacII fragment corresponding to
the hygromycin resistance gene common to all the LoxP
plasmids.
Cell culture and construction of stable cell lines
Both HeLa and chinese hamster ovary (CHO) cells were cul-
tured in DMEM (Cellgro) supplemented with 5% fetal bovine
serum (Atlanta biologicals) and 1· non-essential amino acids
(Invitrogen) in a humidiﬁed atmosphere containing 7% CO2
at 37 C.
The HeLa cell line M2K was generated by stably transfect-
ing the cell line HRM2 (16) with pCMV-TetR(B/E)-KRAB
(13) and pPUR (BD Bioscience). Details will be published
elsewhere (Scha ¨tz, Knott, Hillen and Berens; manuscript in
preparation). To generate the cell line M2PK,  5 · 10
5 cells
were transfected with 2 mg PvuII-linearized pWHE134 using
Lipofectamine (Invitrogen). Twenty-four hours later, cells
were seeded into 15 cm plates and selected with 800 mg/ml
G418 (Invitrogen) for at least two weeks. Positive clones
stably producing the transfected regulators were identiﬁed
by transient transfection of 0.1 mg pUHC13-3 (8) and 0.6 mg
pUHD16-1 for normalization of transfection efﬁciency, and
1.3 mg pWH802 as non-speciﬁc DNA. Clone with the highest
induction of luciferase activity after incubation with 1 mg/ml
dox for 24 h was chosen. Cells were routinely maintained in
medium containing 400 mg/ml G418.
For retroviraldelivery ofL3HyTK2LintoCHO,HeLa M2K
and M2PK cells,  5 · 10
5 cells were infected with culture
supernatant containing RV-L3HyTK2L (as described by
manufacturer). Resistant clones were selected in 400 mg/ml
hygromycin B(Calbiochem)for CHO and 100 mg/ml forHeLa
cells.
L3HyTK2L was also integrated into the dihydrofolate
reductase gene (DHFR) locus of DR-8 (a derivative of
CHOK1) by homologous recombination using the strategy
previously described, generating the stable clone 146-111
(17). For dox inducibility, pWHE134 was stably integrated
into 146-111 by an approach described above, generating
stable line 111-134.
Cre recombination and selection for RMCE derivatives
A total of 30 mg of exchange plasmid and 3 mg of pOG231
were electroporated into  4 · 10
6 cells at 250 V 1500 mF
(Hybaid). Approximately 1 · 10
5 cells were re-plated onto
15 cm tissue culture plate 4 days after electroporation.
Ganciclovir (Moravek Biochemicals) was added the next
day to a ﬁnal concentration of 2 mM. The drug-containing
medium was washed off and replaced with fresh medium
after 3 days. Colonies were picked between 7 to 10 days
after transferring into fresh medium.
PCR screening
Clones isolated from ganciclovir selection were screened for
recombinants by PCR for loss of HyTK gene and gain of
speciﬁc recombination junctions. A total of 5 ng of genomic
DNA was added to a PCR mix containing 0.2 mM primers,
0.2 mM dNTP mix, 1.5 mM MgCl2 and 0.05 U/ml AmpliTaq
Gold polymerase (Applied Biosystems). Ampliﬁcation was
performed once at 94 C for 10 min, followed by 40 cycles
at 94 C for 30 s, 57 C for 30 s and 72 C for 30 s, followed by
a ﬁnal extension step at 72 C for 10 min. Refer to Figure 1 in
results section for the position of primer pairs used. The same
strategy was employed for HeLa and CHO cells. Primer
sequences are available upon request.
Reporter assays
Cells grown on 35 mm dishes were washed once with
phosphate-buffered saline (PBS) and lysed in 200 ml lysis
buffer [50 mM Tris–HCl (pH 8.0), 5 mM EDTA, 150 mM
NaCl, 0.5%NP-40,1·complete proteaseinhibitor mix(Roche
Figure 1. PrincipleofRMCEandscreening strategyforrecombinants.The positive-negativeselection markerHyTKthat confersresistance to hygromycin (Hyg
R)
andsensitivitytoganciclovir(Gan
S)isflankedbyapairofheterospecificLoxPsitesplacedininvertedorientation(invertedtriangles)andintegratedasasinglecopy
intoagenomicsite.InthepresenceofCre-recombinaseandincomingDNAharboringthesamepairofLoxPsites,exchangewillreplacetheexistingHyTKwithDNA
ontheexchangeplasmid.CellsthathavesuccessfullyundergoneRMCEcanbeselectedbasedonresistancetoganciclovir.ThetetracyclineinducibleLucGFP(TRE-
LucGFP) is used as the reporter to characterize uniformity of gene expression between clones after integration into the genome. Also shown are the positions of
BamHI site and Luc probe used for Southern blot and primer pairs (P1–P6) used for screening of recombinants.
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of cell lysate was then mixed with 100 ml of luciferase reagent
[20 mM Tricine, 1.07 mM MgCO3, 2.67 mM MgSO4, 0.1 mM
EDTA, 33.3 mM DTT, 270 mM coenzyme A (USBiological),
530mM ATP and 470 mM luciferin (Molecular Probes)]before
reading on the luminometer (Lumat LB9507). Luciferase
activity was normalized to total protein content (BioRad
Laboratories). GFP ﬂuorescence was analyzed by passing sin-
gle cell suspensions in PBS through the FACScan (Becton
Dickenson).
Determination of population doublings
The population doubling is calculated based on the formula
3.34 (logNi-logNf), where Ni is the initial cell count and Nf is
the ﬁnal cell count.
RESULTS
Designing a new LoxP site
The success of directional RMCE relies on the use of two
heterospeciﬁc LoxP sites ideally exhibiting no recombination
with each other. The natural LoxP (L2) site and the mutant
LoxP511 (L1) are commonly used (1,12), but they differ
by only 1 bp in the central 8 bp spacer region. A plasmid
bearing L1 and L2 sites (pL1L2) can recombine illegitimately
when cotransfected with the Cre-recombinase plasmid
(compare Lane 1 and Lane 2 in Figure 2c). As such recomb-
ination reduces the effectiveness of RMCE, we designed a
new LoxP site (designated LoxP257 or L3; see Figure 2a)
that differs from the original LoxP site by 3 nt. A plasmid
carrying a pair of L3 sites (pL3L3) recombines efﬁciently
with itself in the presence of Cre-recombinase (compare
lanes 3 and 5 in Figure 2c). More importantly, no recombina-
tion was detected in a plasmid containing L3 and the
inverse L2 (2L) site (pL32L) in the presence of Cre
(compare lanes 4 and 6). Thus, the newly designed L3 site
paired with L2 is more ideal for RMCE than is the pair L1
and L2.
Highly efficient RMCE by L3-2L after integration
into the genome
We next perform a vigorous test for the efﬁciency of cassette
exchange mediated by L3 and L2. L3 and L2 are integrated
into the genome of CHO and HeLa cells by homologous
recombination or retroviral delivery. CHO was chosen
because it is a commonly used cell line for the expression
of recombinant proteins of pharmaceutical value (18–20)
and because of our ongoing studies of DNA replication control
in the DHFR locus. HeLa was chosen because it is commonly
used for analyses of a variety of biological processes and is
Figure 2. ConstructionandcharacterizationofnewLoxPsiteforRMCE.(a) Sequenceofthe8bpspacer foundwithintheLoxPsite.LoxPandLoxP511 arenamed
accordingtopreviouslypublished(12).RecombinationoccursefficientlybetweenLoxPsiteswithidenticalspacersequence.Changestothesequencewithinthe8bp
spacergeneratesLoxPsitesthatrecombinewiththemselvesbutnotwithotherLoxPsites.Underlinedbase(s)representsthebasechangethatdiffersfromtheoriginal
L2 sequence. (b) A schematic of the three test plasmids (or I ¼ input DNA), pL1L2, pL3L3 and pL32L and the possible products of RMCE (R ¼ recombinant).
ShownarethepositionsoftheLoxPsites,therestrictionsitesusedfortheSouthernblotanalysis(S ¼ SspI,N ¼ NdeI),andthetargetsequencefortheprobe(black
box). The sizes of the predicted restriction fragments are listed below. The boxed fragment corresponds to that detected by the probe. Note that only the L3L3
intramolecularrecombinationwouldbepredictedto occurifL1, L2andL3donotrecombine witheachother.(c)Southernblotanalysisoftestplasmidstransfected
into293cellsintheabsenceorpresenceofaCre-expressingplasmid[pOG231,(14)].Bandsweredetectedusingaprobetothehygromycinsequencecommontothe
test plasmids. Unrecombined, input plasmids are marked with ‘I’; products of Cre recombination are marked with ‘R’. Note the presence of a non-specific band in
lanes 3 and 5 marked with an asterisk.
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phosphotransferase-thymidine kinase (HyTK) gene for both
positive and negative selections (1). The HyTK fusion gene,
which confers resistance to hygromycin and sensitivity to
ganciclovir, was ﬂanked by L3 and L2 (L3HyTK2L). This
cassette was ﬁrst inserted into the DHFR locus in CHO
cells by homologous recombination. The DHFR locus was
chosen due to our interest in its replication domain and
because it can be ampliﬁed to high levels in the presence
of methotrexate (21), which may be used to enhance produc-
tion of proteins of biological interest (21,22). Also, robust
procedures are available for homologous recombination
between a cosmid carrying the 30 half of the DHFR coding
sequence with DR-8 (a DHFR-deﬁcient CHO cell line hem-
izygous for a 30 truncated DHFR gene) (23,24) (Figure 3a).
This reconstructs the full-length DHFR gene, which is readily
identiﬁed by growth of cells in medium lacking thymidine,
hypoxanthine and glycine (17). We modiﬁed the targeting
vector to include the L3HyTK2L cassette downstream of the
DHFR gene. Southern blot analysis using probes spanning
different regions of the DHFR locus conﬁrmed the reconstruc-
tion of the DHFR gene and a probe for HyTK conﬁrmed
the integration of the L3HyTK2L cassette (Figure 3b), this
clone is now named 146-111.
We next used retroviruses to insert single copies of the
L3HyTK2L cassette into HeLa (Figure 3c) or CHO cells gen-
ome (data not shown). Southern blot analysis using a probe
against HyTK demonstrated single copy integration at random
sites in the genome of different clones (Figure 3d). Four HeLa
clones and one CHO (CHO #4) clone exhibiting high and
stable expression of HyTK [assayed by western blot for TK
expression, (data not shown); polyclonal antibody against
TK kindly provided by Ian R Wickersham] were used for
subsequent recombination experiments.
To test the efﬁciency of recombination at the genomic site,
plasmid DNA containing L3 and L2 sites was electroporated
with a Cre-expressing plasmid (14) into the previously
constructed CHO and HeLa parental lines containing
L3HyTK2L cassette (L3-2L parent). LoxP sites, L3 and L2,
were placed as inverted repeats to eliminate the possibility
of recombination and deletion of the selection gene. Recom-
binants were selected based on resistance to ganciclovir
after the replacement of the TK gene (Figure 1). A clone
that is resistant to ganciclovir can either lose the TK gene
by RMCE or has retained TK but silenced its expression
or mutationally inactivated it. We identiﬁed recombinants
that underwent RMCE using PCR to identify clones that
lost the TK gene and gained the predicted recombinant junc-
tions (Figure 1 and Table 1). Single copy integration of the
incoming DNA was also conﬁrmed by Southern blot analysis
(Supplementary Data).
The overall frequency of correct recombination was 81%
for CHO and 69% for HeLa cells (Table 1). The efﬁciency of
recombination does not appear to be affected by the size of
the incoming DNA, as fragments between the lengths of 100
to 4000 bp recombined with similar frequencies (Table 1). All
clones that were negative for recombination junctions were
positive for HyTK by PCR, suggesting that they arise due
to silencing of the TK gene. No clone was tested positive
for inversion between LoxP sites or illegitimate deletion of
the TK sequence (Table 1).
Uniform and stable doxycycline-inducible expression
of transgene by RMCE clones
It has been previously reported that gene expression is uniform
between RMCE clones derived from the same parental line
(1,25). Since it is often essential to regulate the level of gene
expression, we further tested the uniformity and stability in
geneexpressionbycomparinggeneinductioninRMCEclones
containing an integrated copy of L3-TRE-LucGFP-2L. The
Tet-On system we used has been modiﬁed as follows to
enable stringent on-off regulation. The transactivator (rtTA)
is a modiﬁed bacterial TetR protein fused to VP16 transcrip-
tional activation domain (rtTA2
S-M2). It activates gene
transcription by binding to TRE in the presence of dox
(10,11); in the absence of dox, a Tet-transrepressor (tTR),
TetR(B/E)-KRAB, binds TRE and actively represses gene
expression (13).
We tested two ways of generating rtTA and tTR expressing
stable cell lines. In the ﬁrst system, rtTA and tTR were linked
by an IRES element in a single plasmid (pWHE134) and were
transcriptionally controlled by one promoter (single plasmid
Tet-On system exempliﬁed by the M2PK HeLa and CHO
111-134 in Figure 4a). In the second system, rtTA and tTR
genes were on separate plasmids and their expression were
driven from two independent promoters (two plasmid Tet-On
system in HeLa cell line M2K in Figure 5a).
Gene expression was induced at a saturating dose of dox
(2 mg/ml) for 72 h followed by a luciferase assay to determine
the maximum induction attained by each RMCE clone. To
compare uniformity in gene expression between clones, cells
were induced at a non-saturating dose of dox followed by
single cell analysis for GFP ﬂuorescence using ﬂow cyto-
metry. We ﬁrst tested the dose response to dox by titrating
the concentration of dox and measuring the mean ﬂuorescence
units at 3 days (Figure 4b and c) after induction. Flow cyto-
metric analysis showed uniform GFP expression in the
induced populations and the ﬂuorescence increased in a
dose-dependent manner in CHO 111-134 cells from 12.5 to
200 ng/ml. A similar titration experiment was performed for
HeLa cells (data not shown). Dox used between 50 and
100 ng/ml for CHO 111-134 and HeLa cells, respectively,
fell within the linear range of induction and was chosen to
test the uniformity in gene expression in the RMCE clones.
The single plasmid Tet-On system in HeLa cells (M2PK
in Figure 4) generates low basal luciferase activity in the
un-induced state and high level of luciferase activity at
high dox concentration in all the four RMCE clones tested
(Figure 4d). The fold increase in luciferase activity ranged
from 3 · 10
4-t o7· 10
4-fold over the un-induced state in
these clones. Three of four RMCE clones exhibited greater
than 90% GFP expression while one exhibited greater than
70% expression after induction with sub-maximal dose of dox
(Figure 4e). Three clones had mean GFP ﬂuorescence ranging
between 90–110 and one clone had a mean GFP ﬂuorescence
of about 70. These data show that within single clones, indi-
vidual cells exhibited similar expression levels, though we did
detect some inter-clonal variability.
In CHO 111-134, all ﬁve clones derived by RMCE at the
DHFR locus showed high luciferase activities upon induction
at 2 mg/ml dox whereas the expression of luciferase was close
to background in the absence of dox (Figure 4d). The fold
PAGE 5 OF 13 Nucleic Acids Research, 2005, Vol. 33, No. 17 e147Figure 3. Integration and analysis of L3-2L introduced into the genomes of CHO and HeLa cells. (a) Engineering L3-2L into DR-8 cell line by homologous
recombination using the strategy described by Kalejta et al., (17). The diagram shows the genomic structure at the DHFR locus (wild-type), sizes of the fragments
generated by EcoRI digestion and the positions of the probes used for Southern blot. Targeting cosmid DNA containing the 30 half of the DHFR gene is used to
reconstructtheentiregeneinDR-8celllinethatcontainstruncationatthe30 endoftheDHFRgene.TheL3andL2sitesareplacedininvertedorientationandflanking
theHyTKpositive-negativeselectablemarkergene.TheentirecassettewasinserteddownstreamofDHFRgeneafterhomologousrecombination.(b)Southernblot
ofgenomicDNAderivedfromCHOcellshemizygousforwild-typeDHFR[WT/-orUA21(17)],30 truncatedDHFR[delta/-orDR-8(17)]andHyTKreconstituted
cells(HyTK/-or146-111).DNAwasrestrictedwithEcoRIbeforeblottingandthepositionsofthebandsgeneratedbyeachprobeareindicatedwithanarrow.Probe
121marksthe50 flankofthecosmidDNA,probe100testsforreconstructionatthe30 endoftheDHFRgene,probe12/38indicatesthepresenceofori-beta(b),probe
eightmarksthe30 flankofthecosmidDNA,andprobeHyTKindicatestheinsertionofHyTKintothegenome.M,molecularweightmarker.(c)Schematicdiagramof
retrovirus RV-L3HyTK2L. L3 and L2 are placed in inverted orientation flanking HyTK gene. Also shown is the position of the BamHI site and the probe used for
Southern blot. Upon integration into the genome, the expected size of the fragment generated by BamHI is 4 + x kb. (d) Southern analysis to determine the copy
numberofintegratedHyTKgeneintheHeLacellclones(1to10)derivedafterinfectionwithRV-L3HyTK2L.GenomicDNAwasrestrictedwithBamHIandprobed
against HyTK gene. Positive control (+) is original retrovirus DNA used to generate the stable line. P, parental HeLa.
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3 to 4 · 10
4.
As shown in Figure 4e, ﬁve out of ﬁve RMCE clones were
greater than 92% GFP positive after induction at sub-maximal
dose. Clone 1 had the highest mean GFP ﬂuorescence (236)
while clone 3 showed the lowest mean GFP ﬂuorescence (94).
Other RMCE clones had mean GFP ﬂuorescence 105, 107 and
138, respectively. These results indicated that the reporter
gene expression in these RMCE clones derived from the
L3HyTK2L CHO parentalcell linehad substantial inducibility
and uniformity.
In the two plasmid Tet-On system (M2K HeLa cells in
Figure 5), basal luciferase activity was relatively low and
uniform across the four clones analyzed. The maximum
fold induction in luciferase activity ranged from 1 · 10
4 to
3 · 10
4 in the clones analyzed (Figure 5b). Three of the four
RMCE clones tested show greater than 80% green cells
after induction and exhibited mean GFP ﬂuorescence between
100 and 110 (Figure 5c). One of the clones showed greater
than 50% green cells and mean GFP ﬂuorescence of 86 upon
induction.
The RMCE approach enables genes to be independently
introduced into a single genomic locus. Comparison between
genes obtained from independent RMCE experiments is pos-
sible if the level of gene expression is preserved in clones
obtained from independent RMCE experiments. Using the
same L3-2L parent (HeLa M2K), we compared GFP expres-
sion in clones obtained from two independent RMCE experi-
ments performed at the same genomic locus (Figure 5d).
Seven out of ten clones obtained in the second RMCE experi-
ment had similar mean GFP ﬂuorescence level as 3 out of 4 of
the clones obtained in the ﬁrst RMCE experiment.
We evaluated whether the inducible phenotype was stable
over time using one representative RMCE clone from M2PK
and one from M2K HeLa. These clones were continuously
passaged for 1 month before analysis. The basal GFP level
remained low, and dox addition produced robust GFP induc-
tion when assayed 1 month later. Uniformity of expression in
M2PK #1 was very high over this time period (i.e. 90% of cells
exhibited GFP ﬂuorescence after 1 month, compared to 92%
originally). (Figure 6). However, the mean GFP ﬂuorescence
and the percentage of GFP expressing cells after induction
declined slightly in HeLa M2K #3 (Figure 6).
Monitoring population doubling by Tet-regulated
H2BGFP expression
The highly inducible nature of this system suggested potential
applications for transiently marking individual cells to ‘pulse
label’ them. As one example, we previously generated a very
stable histone H2BGFP fusion protein that is readily incor-
porated into chromatin to generate brilliantly ﬂuorescent chro-
mosomes and nuclei (26). We reasoned that if the H2BGFP
gene was induced for several cell doublings to uniformly label
the chromatin in each cell, and it was then turned off, the
ﬂuorescence of the cell would be diminished by a factor of
two each time the cell divided since nucleosomes segregated
randomly when DNA is replicated (27). Thus, ﬂuorescence
microscopy or ﬂow cytometry could be used to determine
how many times a cell doubled by merely measuring its
ﬂuorescence intensity relative to that at the beginning of
the experiment.
Figure 7 shows a ﬂow cytometric analysis of the ﬂuores-
cence intensity of HeLa cells followed for seven population
doublings. The decrease in ﬂuorescence per population doub-
ling is precisely that expected for a 2-fold decrease per cell
division. Importantly, there was no decrease in ﬂuorescence
observed in cells that were held in quiescence by thymidine
block (Figure 7a). This shows that the decreased ﬂuorescence
required entry into and progression through S-phase, and was
not the result of H2BGFP degradation.
Table 1. RMCE efficiency in cell lines tested
Parental
line
L3-2L
clones
RMCE exchange plasmid Cre plasmid
pOG231 (mg)
PCR for junction
(no. +ve/no. tested)
PCR for HyTK
gene (no. +ve/no. tested)
% Recombination
CHO 4 10mg L3-SV40bGal-2L 1 5/5 0/5 100
30mg L3-SV40bGal-2L 3 5/5 0/5 100
60mg L3-SV40bGal-2L 6 5/5 0/5 100
0mg 3 0/3 3/3 0
10mg L3-SV40bGal-2L 0 0/3 3/3 0
30mg L3-IndbGal-2L 3 6/12 6/12 50
CHO 146-111 30mg L3 DHFR 207 bp 2L 3 8/11 3/11 73
30mg L3 DHFR 109 bp 2L 3 12/12 0/12 100
30mg L3 DHFR 101 bp 2L 3 11/12 1/12 92
30mg L3 DHFR 2400 bp 2L 3 8/12 4/12 67
30mg L3 DHFR 2299 bp 2L 3 12/12 0/12 100
30mg L3 DHFR 2291 bp 2L 3 8/10 2/10 73
30mg L3-TRE-LucGFP-2L 3 7/12 5/12 58
Overall frequencies in CHO 81
HeLa M2K2 30mg L3-TRE-LucGFP-2L 3 4/7 3/7 57
M2K3 30mg L3-TRE-LucGFP-2L 3 6/8 2/8 67
M2PK7 30mg L3-TRE-LucGFP-2L 3 5/8 3/8 63
M2PK10 30mg L3-TRE-LucGFP-2L 3 3/3 0/3 100
Overall frequencies in HeLa 69
TwodifferentlociweretestedinCHOandfourindependentsitesweretestedinHeLa.TheL3-2LsiteinCHO#4wasgeneratedbyretrovirusintegration.LoxPsitesin
CHO146-111wereintroducedbyhomologousrecombinationintotheDHFRlocus.AllRMCEcloneswerescreenedbyPCRandscoredforpositiveRMCEjunctions
(P3 + P4andP5 + P6)andpositiveforTK(P1 + P2)usingprimerpairsindicatedinFigure1.Thepercentageofsuccessfulrecombinantsisexpressedasthenumberof
positive junctions over the total number of clones tested.
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We have combined the powers of RMCE and regulated gene
expression into a single highly efﬁcient system that should
facilitate structure-function studies, enable production of
biopharmaceuticals, or provide a means of tracking cell
proliferation in real time. The Cre/LoxP recombination system
is preferred for site-speciﬁc recombination because it exhibits
higher efﬁciency of recombination over the Flp/FRT system in
speciﬁc cell types such as mouse embryonic stem cells and
primary cells (28–31). However, the system we describe could
as easily be implemented using engineered Flp recombination
target sequences designed not to recombine with each
other. We ﬁrst engineered a new LoxP site to minimize intra-
chromosomal exchanges that generate deletions, and to max-
imize exchanges between the chromosomal and plasmid
donor LoxP targets. To minimize the need for drug selection
markers, we introduced into the chromosomal target a HyTK
fusion gene. This enables positive selection to identify clones
containing the LoxP target, and then counterselection using
gancyclovir to select for loss of the chromosomal target and
concomitant replacement with the donor plasmid. This is
especially valuable for situations in which introduction of
extraneous transcriptional control sequences needs to be
avoided. We also used an optimized Tet-On system to enable
robust controlled expression of the donated sequences. This
should allow for analyses of phenotypic effects of the intro-
duced gene when it is expressed at normal, sub- or supra-
physiologic levels.
We tested the system by ﬁrst analyzing the stringency of
recombination with the newly characterized L3 LoxP site. A
pair of heterospeciﬁc recombination sites that do not recom-
bine with each other is necessary for efﬁcient RMCE (6).
When used with the original LoxP site (L2), the ﬁrst LoxP
variant (LoxP511 or L1) that was generated greatly enhanced
the frequencies of exogenous gene integration when coupled
withpositiveselection (12).However,usingnegativeselection
as a means to enrich for recombinants, the efﬁciencies were
markedly different (1,6). Deletion of intervening sequences
without replacement occurred when L2 and L1 were placed as
direct repeats, suggesting interaction between L1 and L2 (6).
When placed as inverted repeats, inversion of the intervening
sequence resulted in an equal proportion of clones in either
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ality of the integrant is important. We solved the problem of
recombination between L2 and L1 by generating a new LoxP
site, LoxP257 (L3), which was designed based on ﬁndings
from in vitro recombination assays (5). L3 differs from L2
by three bases within the 8 bp spacer sequence. When used
in combination with L2 and L3 generated recombinants at
high frequency, suggesting the feasibility of using L3 and
L2 for RMCE. The ﬁnding was consistent with a previous
study showing that a modiﬁed LoxP sequence (LoxP2272)
Figure 4. GFP induction by single plasmid Tet-On CHO 111-134 and HeLa M2PK RMCE clones. The RMCE clones were named after the L3-2L parent that they
werederivedfrom.(a)SchematicdiagramshowingthevariousgenesthatwereincorporatedtomakeuptheRMCEclones.InCHO111-134andHeLaM2PK,rtTA
andtTRgenesarelinkedbyIRESandtranscriptionallydrivenbyonepromoter.Neo
Rcodesforneomycin/G418resistancegene.TheL3-TRE-LucGFP-2Lcassetteis
insertedassinglecopyintothegenomebyRMCEasdescribedinFigure1.(b)HistogramplotshowinggreenfluorescenceexhibitedbyCHO111-134afterinduction
with increasing concentration of dox for 72 h. (c) Graph shows the mean fluorescence units exhibited by CHO 111-134 after induction with increasing dox
concentrationsfor72h.Dataareobtainedfromtwoindependentexperiments.(d)Normalizedluciferaseactivitytoshowmaximumgeneinductionincellsbeforeand
after incubationwith2mg/mldox for72 h.Datarepresentsmean andstandarderrorofthree independent experiments. Parentallines(P)do nothaveluciferasegene
inserted into their genomes. (e) Histogram plots of GFP expression by RMCE derivatives before ( ) and after (+) dox induction in one representative experiment.
HeLaandCHOcellswereinducedwith0.1and0.05mg/mldox,respectivelyfor72hbeforeharvestingforflowcytometry.Eachpopulationwasgated(M1andM2)
and the percentage of the gated cells and their corresponding mean GFP fluorescence are indicated in each plot.
PAGE 9 OF 13 Nucleic Acids Research, 2005, Vol. 33, No. 17 e147Figure5.ReportergeneinductionbytwoplasmidsTet-OnstableHeLaM2KRMCEclones.(a)Schematicdiagramshowingthevariousgenesthatwereincorporated
to make up M2K RMCE clones. Two independent promoters are used to drive the rtTA and tTR genes. The reporter gene LucGFP is inserted into the genome by
RMCE.(b)Normalizedluciferaseactivitytoshowmaximumgeneinductionincellsbeforeandafterincubationwith2mg/mldoxfor72h.Datashownaremeanwith
standard error obtained from three independent experiments. Parental line (P) do not express the luciferase gene. (c) Histogram plots of GFP expression by M2K
RMCEderivativesbefore( )andafter(+)doxinductionat0.1mg/mlfor72h.Cellswereharvestedforflowcytometryandeachpopulationwasgated(M1andM2)
withthecorrespondingpercentageofgatedcellsandmeanGFPfluorescenceshownineachplot.(d)GraphshowsmeanGFPfluorescenceofRMCEclonesobtained
from two independent RMCE experiments. Cells were either un-induced ( ) or treated with 0.1 mg/ml dox for 72 h.
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exchange (6). Other than having a high inter-molecular
recombination efﬁciency, the probability of selecting a
recombinant clone among the ganciclovir resistant clones is
increased when TK expression from the L3HyTK2L parent
line is high and stable. Using this criterion for the selection
of the L3HyTK2L cell line, we observed high efﬁciency,
accurate RMCE in two different mammalian cell lines at
six independent genomic loci. We also observed little size
dependence on RMCE frequency or accuracy. The high
frequency of correctly recombined clones expedites screening
for desirable clones.
We used homologous recombination to introduce
L3HyTK2L into several single copy loci, including the inter-
genic region of the CHO DHFR locus. Our data demonstrate
that the DHFR locus was favorable for RMCE and for tightly
regulated gene induction. Recombination occurred at very
high efﬁciency (50–100%) and we readily obtained clones
exhibiting robust inducible expression (up to 10
4-fold by luci-
ferase, and >100-fold by GFP analyses). This locus offers a
number of advantages for other studies. For example, it can be
readily ampliﬁed using selection for methotrexate-resistance
(21). As CHO cells are often used to produce biopharmaceut-
icals, the combination of ampliﬁcation and highly regulated
expression could provide substantial advantages for reducing
production costs, enabling stable maintenance of transgenes,
and obtaining very high level expression of potentially toxic
proteins. In studies to be presented elsewhere, we found the L2
and L3 sites to be useful for generating genetically engineered
ES cells, mouse embryo ﬁbroblasts, and mice with different
p53 point mutations or fusion genes with high efﬁciency
(F. Toledo, C. Lee and G.M.Wahl,manuscript in preparation).
Using a strategy similar to that employed for the delivery of
Flp/FRT tagged sites into the genome of mammalian cells
(25,32), we integrated the LoxP sites at single copy into ran-
dom positions in the genome of HeLa and CHO cells by
retroviral delivery (Figure 3c). An advantage of the retroviral
Figure 6. Stability of gene induction at the LoxP loci. Histogram plots showing GFP induction in M2K #3 and M2PK #1 before and after 1 month of continuous
passage. Experiments were performed twice and data shown are from one experiment.
Figure7.MonitoringcelldoublingusinginducibleH2BGFP.HeLacellsstably
expressing TRE-H2BGFP were generated by L3-2L mediated RMCE. Cells
wereeithernotinduced( dox)orinducedwith2mg/mldox(+dox)for3days
to achieve maximum expression before washing out the dox in the presence or
absence of 2 mM thymidine. Cells were harvested each day after the removal
of dox and their fluorescence monitored by flow cytometry (Actual fluores-
cence). The expected fluorescence is the theoretical fluorescence value assum-
ing 50% decay after each population doubling. Experiments were performed
twice and data from one experiment are shown as a histogram in (a) and as a
graph in (b).
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efﬁciency and at single copy (Figure 3d) into the genome.
Active transcription sites are the preferred retroviral integra-
tion sites (33,34). Consistent with this, we were able to select
retroviral integrations at high efﬁciency, an advantage over
gene targeting by homologous recombination.
An important advantage of RMCE approach that is valuable
for structure-function studies and production of recombinant
proteins of pharmaceutical value is the ability to repeatedly
obtain clones exhibiting predictable and uniform gene expres-
sion at high frequencies (1,25,35). We combined that with the
improved version of the Tet-On inducible system to evaluate
the reproducibility of gene induction at each locus (11). By
single cell analysis, GFP was uniformly expressed within the
population and it was induced in a dose-responsive manner.
The improved rtTA (rtTA2
s-M2) demonstrated many superior
properties over the original rtTA. Beside the ability to induce
graded transgene expression, induction exhibited a greater
dynamic range, higher sensitivity to dox and faster induction
rate (within 24 h, data not shown) compared to the original
rtTA system (Figure 4b and c) (11,36). Recombinants derived
from the same L3-2L parental line have the reporter gene
inserted at the same genomic locus. As expected, the majority
of the RMCE clones obtained in one experiment showed
similar levels of expression upon induction (Figures 4 and 5).
The uniformity in gene expression was also found between
clones obtained from independent RMCE experiments
(Figure 5d). Hence, clones that reproducibly induce different
transgenes can be readily obtained through multiple rounds
of RMCE.
Maintaining stable transgene expression is as important as
high transgene expression. Since transgene expression may be
subjected to silencing, especially when viral promoter is used
to drive gene expression (37,38) and when expression is not
maintained under selective pressure (39). We measured the
stabilityofexpressioninHeLa cells afteratleast30 population
doublings in culture. We observed that the level of inducib-
ility, and the fraction of cells expressing the transgene, was
stable over the time period studied when transcription of rtTA
and tTR were coupled to that of the neomycin resistance gene
by the IRES elements and by maintaining the culture under
G418 selection. Hence, the use of IRES to mediate coexpres-
sion of multiple genes will gain popularity in both in vitro and
in vivo applications (40,41).
The tight and reversible gene expression regulated by the
Tet-On system was further demonstrated by switching
H2BGFP expression on and then off to monitor cell doubling
(Figure 7) as a function of ﬂuorescence units. H2BGFP is
incorporated into the chromatin after synthesis, and tracks
with nucleosomes that are segregated randomly to daughter
cells during each division (27). Being a stable protein,
H2BGFP ﬂuorescence should approximately halve with
each division if its expression is prevented. Consistent with
this prediction, after H2BGFP expression was turned off for
different numbers of population doublings, ﬂow cytometric
analysis revealed the expected 2-fold decay per population
doubling (Figure 7). Hence, the inducible expression of
H2BGFP can be used to measure population doublings within
a deﬁned time frame. For example, as stem cells are expected
to divide fewer times than transit amplifying cells, the reten-
tion of H2BGFP ﬂuorescence should be able to be used as a
marker to localize putative stem cells in situ and as a means to
isolate them by ﬂuorescence based cell sorting (42–44).
In conclusion, the LoxP/Cre recombination system offers
reproducible and directionalDNAintegrationinto speciﬁcloci
in the genome at high frequency. The single plasmid Tet-On
system, which ensures stable expression of the transactivator
and transrepressor, allows reproducible and graded induction
of transgenes to a similar level in the RMCE clones derived
from single and independent recombination experiments.
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